Skip to main content

Table 1 Demographics

From: CXCR2 antagonist for patients with chronic obstructive pulmonary disease with chronic mucus hypersecretion: a phase 2b trial

 

Number of participants, N (%)

Placebo (N = 102)

DNX 5 mg (N = 102)

DNX 10 mg (N = 103)

DNX 25 mg (N = 103)

DNX 35 mg (N = 102)

DNX 50 mg (N = 102)

Age (years)

 Mean (SD)

66.2 (7.3)

66.3 (6.8)

65.7 (7.5)

66.3 (7.3)

65.1 (7.6)

65.7 (7.0)

 Median

67.0

66.5

66.0

67.0

65.0

66.0

Age group (years)

 18–64

43 (42)

38 (37)

45 (44)

40 (39)

46 (45)

47 (46)

 65–74

46 (45)

52 (51)

47 (46)

47 (46)

45 (44)

40 (39)

 75–84

13 (13)

12 (12)

11 (11)

16 (16)

11 (11)

15 (15)

Sex

 Female

29 (28)

36 (35)

32 (31)

38 (37)

35 (34)

32 (31)

 Male

73 (72)

66 (65)

71 (69)

65 (63)

67 (66)

70 (69)

Ethnicity

 Hispanic/Latino

1 (< 1)

0

1 (< 1)

3 (3)

1 (< 1)

3 (3)

 Not Hispanic/Latino

101 (> 99)

102 (100)

102 (> 99)

100 (97)

101 (> 99)

99 (97)

Race

 Asian - East Asian Heritage

10 (10)

6 (6)

18 (17)

17 (17)

10 (10)

17 (17)

 Asian - South East Asian Heritage

1 (< 1)

0

0

0

0

0

 Black or African American

2 (2)

2 (2)

1 (< 1)

0

0

1 (< 1)

 Native Hawaiian or other Pacific Islander

1 (< 1)

0

0

0

0

0

 White - Arabic/North African Heritage

1 (< 1)

1 (< 1)

0

0

0

0

 White - White/Caucasian/European Heritage

87 (85)

93 (91)

84 (82)

86 (83)

92 (90)

84 (82)